ClearPoint Neuro (CLPT) FCF Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 3,608.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,608.00 |
| Dec 31, 2025 | -5,628.00 |
| Sep 30, 2025 | 3,873.00 |
| Jun 30, 2025 | 6,857.00 |
| Mar 31, 2025 | 1,133.00 |
| Dec 31, 2024 | 6,446.00 |
| Sep 30, 2024 | 5,988.00 |
| Jun 30, 2024 | 7,396.00 |
| Mar 31, 2024 | 360.00 |
| Dec 31, 2023 | 4,714.00 |
| Sep 30, 2023 | 360.00 |
| Jun 30, 2023 | -2,180.00 |
| Mar 31, 2023 | -3,228.00 |
| Dec 31, 2022 | -6,620.00 |
| Sep 30, 2022 | -4,326.00 |
| Jun 30, 2022 | -6,617.00 |
| Mar 31, 2022 | -6,158.00 |
| Dec 31, 2021 | -5,822.00 |
| Sep 30, 2021 | -2,020.00 |
| Jun 30, 2021 | -3,848.00 |
| Mar 31, 2021 | 6,818.00 |
| Mar 31, 2019 | 9,878.00 |
| Sep 30, 2018 | 8,333.00 |
| Jun 30, 2018 | 990,901.00 |
| Mar 31, 2018 | 16,516.00 |
| Mar 31, 2016 | 133,861.00 |
| Sep 30, 2015 | 3,554.00 |
| Jun 30, 2015 | -896,130.00 |
| Mar 31, 2015 | 145,611.00 |
| Dec 31, 2014 | 3.38 Mn |
| Sep 30, 2014 | -25,488.00 |
| Jun 30, 2014 | 247,223.00 |
| Mar 31, 2014 | 3,654.00 |